• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乐多康对……的生长抑制作用 (原文不完整,翻译到此)

Growth Inhibitory Effect of Lactocare on .

作者信息

Asadi Mahsa, Fazeli Mohamad Reza, Sabokbar Azar

机构信息

Dept of Microbiology, Islamic Azad University, Karaj branch, Karaj, Iran.

Dept of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Iran J Pathol. 2018 Summer;13(3):301-307. Epub 2018 Sep 12.

PMID:30636952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6322523/
Abstract

BACKGROUND AND OBJECTIVE

Acute microbial diarrheal diseases are the major public health problems in the developing countries. People affected by diarrheal diseases have the lowest financial resources and poorest hygienic facilities. Children under five, primarily in Asian and African countries, are mostly the subjects affected by microbial diseases transmitted through water.The current study aimed at investigating the comparative inhibitory effect of Lactocare (commercial probiotic) on clinical samples and standard strains of .

METHODS

A total of 20 clinical samples and a standard strain ) were provided by Health Reference Laboratory and Biotechnology Institute, respective ly. In order to confirm the samples, biochemical analysis and the polymerase chain reaction (PCR) were performed on intergenic space. Afterward, agar well diffusion method was performed in order to measure the minimum inhibitory concentration to monitor the antimicrobial activity of Lactocare.

RESULTS

Colony count of V. for the standard strain in 30% and mean for clinical samples in 50% concentration of Lactocare treatment revealed that it would propel to death phase. Since the number of colonies decreased to 100, it was considered that higher concentrations of Lactocare would completely inhibit the growth of .

CONCLUSION

Probiotics are employed to develop new pharmaceutical preparations and functional foods in order to promote the public health.

摘要

背景与目的

急性微生物性腹泻疾病是发展中国家的主要公共卫生问题。受腹泻疾病影响的人群财力资源最少且卫生设施最差。主要在亚洲和非洲国家的五岁以下儿童大多是受通过水传播的微生物疾病影响的对象。本研究旨在调查Lactocare(商业益生菌)对临床样本和标准菌株的比较抑制作用。

方法

健康参考实验室和生物技术研究所分别提供了总共20份临床样本和一株标准菌株。为了确认样本,对基因间隔区进行了生化分析和聚合酶链反应(PCR)。之后,采用琼脂孔扩散法测量最低抑菌浓度,以监测Lactocare的抗菌活性。

结果

在30%浓度的Lactocare处理下,标准菌株的副溶血性弧菌菌落计数以及50%浓度处理下临床样本的菌落计数均值显示其将进入死亡期。由于菌落数降至100,因此认为较高浓度的Lactocare会完全抑制副溶血性弧菌的生长。

结论

益生菌被用于开发新的药物制剂和功能性食品以促进公众健康。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f6c/6322523/c7a7b1f965db/ijp-13-301-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f6c/6322523/56eb504145b4/ijp-13-301-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f6c/6322523/d9ef17313ffa/ijp-13-301-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f6c/6322523/c7a7b1f965db/ijp-13-301-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f6c/6322523/56eb504145b4/ijp-13-301-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f6c/6322523/d9ef17313ffa/ijp-13-301-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f6c/6322523/c7a7b1f965db/ijp-13-301-g003.jpg

相似文献

1
Growth Inhibitory Effect of Lactocare on .乐多康对……的生长抑制作用 (原文不完整,翻译到此)
Iran J Pathol. 2018 Summer;13(3):301-307. Epub 2018 Sep 12.
2
Application of a paper based device containing a new culture medium to detect Vibrio cholerae in water samples collected in Haiti.一种含有新型培养基的纸质设备在检测海地采集的水样中霍乱弧菌方面的应用。
J Microbiol Methods. 2017 Feb;133:23-31. doi: 10.1016/j.mimet.2016.12.014. Epub 2016 Dec 19.
3
Anti-biofilm Properties of the Fecal Probiotic Lactobacilli Against spp.粪便益生菌乳杆菌对 spp. 的抗生物膜特性
Front Cell Infect Microbiol. 2018 Apr 24;8:120. doi: 10.3389/fcimb.2018.00120. eCollection 2018.
4
Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015.2012年至2015年莫桑比克霍乱疫情期间分离出的埃尔托型霍乱弧菌O1的抗生素耐药性
PLoS One. 2017 Aug 8;12(8):e0181496. doi: 10.1371/journal.pone.0181496. eCollection 2017.
5
Multidrug resistant Vibrio cholerae O1 from clinical and environmental samples in Kathmandu city.来自加德满都临床和环境样本的多重耐药性霍乱弧菌O1
BMC Infect Dis. 2015 Feb 27;15:104. doi: 10.1186/s12879-015-0844-9.
6
Cholera outbreak caused by drug resistant Vibrio cholerae serogroup O1 biotype ElTor serotype Ogawa in Nepal; a cross-sectional study.尼泊尔由耐药性霍乱弧菌O1群埃尔托生物型小川血清型引起的霍乱疫情;一项横断面研究。
Antimicrob Resist Infect Control. 2016 Jun 4;5:23. doi: 10.1186/s13756-016-0122-7. eCollection 2016.
7
Inhibitory activities of Typhonium trilobatum (L.) Schott on virulence potential of multi-drug resistant toxigenic Vibrio cholerae.三叶半夏对多重耐药产毒霍乱弧菌毒力潜能的抑制活性
Microb Pathog. 2022 Apr;165:105485. doi: 10.1016/j.micpath.2022.105485. Epub 2022 Mar 19.
8
Temporal-Spatial Distribution of Vibrio cholerae in Cuba: July 1997-December 2019.1997年7月至2019年12月古巴霍乱弧菌的时空分布
MEDICC Rev. 2022 Oct 31;24(3-4):24-29. doi: 10.37757/MR2022.V24.N3-4.4.
9
In vitro antibacterial activity of onion (Allium cepa) against clinical isolates of Vibrio cholerae.洋葱(葱属)对霍乱弧菌临床分离株的体外抗菌活性。
J Ayub Med Coll Abbottabad. 2010 Apr-Jun;22(2):160-3.
10
Laboratory evaluation of the rapid diagnostic tests for the detection of Vibrio cholerae O1 using diarrheal samples.应用腹泻样本对霍乱弧菌 O1 的快速诊断检测的实验室评估。
PLoS Negl Trop Dis. 2021 Jun 15;15(6):e0009521. doi: 10.1371/journal.pntd.0009521. eCollection 2021 Jun.

本文引用的文献

1
Technical guidance - Update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance.技术指南——更新用于评估对人用或兽用重要抗生素的细菌耐药性的标准。
EFSA J. 2008 Jul 14;6(7):732. doi: 10.2903/j.efsa.2008.732. eCollection 2008 Jul.
2
Waterborne infectious diseases--could they be consigned to history?水源性传染病——它们会成为历史吗?
Science. 2006 Aug 25;313(5790):1077-81. doi: 10.1126/science.1127184.
3
Probiotics and their fermented food products are beneficial for health.
益生菌及其发酵食品对健康有益。
J Appl Microbiol. 2006 Jun;100(6):1171-85. doi: 10.1111/j.1365-2672.2006.02963.x.
4
Molecular phylogenetic analysis of Vibrio cholerae O1 El Tor strains isolated before, during and after the O 139 outbreak based on the inter-genomic heterogeneity of the 16S-23S rRNA intergenic spacer regions.基于16S - 23S rRNA基因间隔区的基因组间异质性,对在O139霍乱暴发之前、期间和之后分离的霍乱弧菌O1 El Tor菌株进行分子系统发育分析。
J Biosci. 2005 Dec;30(5):619-25. doi: 10.1007/BF02703562.
5
Probiotics as modulators of the gut flora.益生菌作为肠道菌群的调节剂。
Br J Nutr. 2002 Sep;88 Suppl 1:S39-49. doi: 10.1079/BJN2002628.
6
Simple procedure for rapid identification of Vibrio cholerae from the aquatic environment.从水生环境中快速鉴定霍乱弧菌的简易方法。
Appl Environ Microbiol. 2002 Feb;68(2):995-8. doi: 10.1128/AEM.68.2.995-998.2002.
7
Analysis of 16S-23S rRNA intergenic spacer of Vibrio cholerae and Vibrio mimicus for detection of these species.分析霍乱弧菌和拟态弧菌的16S-23S rRNA基因间隔区以检测这些菌种。
Methods Mol Biol. 2002;179:171-8. doi: 10.1385/1-59259-238-4:171.
8
Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics.炎症性肠病:免疫诊断、免疫治疗和生态治疗
Gastroenterology. 2001 Feb;120(3):622-35. doi: 10.1053/gast.2001.22122.
9
Probiotic bacteria: safety, functional and technological properties.益生菌:安全性、功能及技术特性
J Biotechnol. 2000 Dec 28;84(3):197-215. doi: 10.1016/s0168-1656(00)00375-8.
10
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.口服细菌疗法作为慢性袋炎患者的维持治疗:一项双盲、安慰剂对照试验。
Gastroenterology. 2000 Aug;119(2):305-9. doi: 10.1053/gast.2000.9370.